Provectus Biopharmaceuticals Files 8-K on Shareholder Vote Matters
Ticker: PVCT · Form: 8-K · Filed: Jun 20, 2025 · CIK: 315545
| Field | Detail |
|---|---|
| Company | Provectus Biopharmaceuticals, Inc. (PVCT) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: PVCT
TL;DR
PROVECTUS BIOPHARMACEUTICALS (PVCT) is holding a shareholder vote; details to follow.
AI Summary
On June 18, 2025, Provectus Biopharmaceuticals, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing was made public on June 20, 2025. The company is incorporated in Delaware and headquartered in Knoxville, TN.
Why It Matters
This filing indicates that Provectus Biopharmaceuticals is seeking approval from its shareholders on specific corporate actions, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of matters submitted for a shareholder vote, not an event that inherently introduces new financial or operational risks.
Key Players & Entities
- PROVECTUS BIOPHARMACEUTICALS, INC. (company) — Registrant
- 0001641172-25-015695 (filing_id) — Accession Number
- June 18, 2025 (date) — Earliest event reported
- June 20, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Knoxville, TN (location) — Principal Business Address
FAQ
What specific matters are being submitted to a vote of security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 18, 2025.
On what date was this 8-K filing submitted to the SEC?
The filing was submitted on June 20, 2025.
What is the principal business address of Provectus Biopharmaceuticals, Inc.?
The principal business address is 800 S. Gay Street, Suite 1610, Knoxville, TN 37929.
In which state is Provectus Biopharmaceuticals, Inc. incorporated?
Provectus Biopharmaceuticals, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT).